Articles

The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs

University of Genoa, DiMI, Italy;
Laboratory of Hematology-Oncology European Institute of Oncology IRCCS, Milan, Italy;
University of Genoa, DiMI, Italy;
University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
University of Genoa, DiMI, Italy;
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy;
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy;
University of Genoa,University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
University of Genoa, Department of Internal Medicine and Specialities (DiMI), Italy;
Ospedale Policlinico San Martino, Genoa, Italy;
University of Genoa, DiMI, Italy;
University of Genoa, DiMI, Italy;
University of Genoa, Department of Experimental Medicine (DIMES), Italy;
University of Genoa, Department of Internal Medicine and Specialities (DiMI), Italy;
University of Genoa, Department of Internal Medicine and Specialities (DiMI), Italy;
University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy;
ArQule, One Wall Street, Burlington, MA, USA
ArQule, One Wall Street, Burlington, MA, USA
ArQule, One Wall Street, Burlington, MA, USA
Laboratory of Hematology-Oncology European Institute of Oncology IRCCS, Milan, Italy;
University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
University of Genoa, DiMI; IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
Vol. 105 No. 10 (2020): October, 2020 https://doi.org/10.3324/haematol.2019.224956